[Federal Register Volume 67, Number 208 (Monday, October 28, 2002)]
[Notices]
[Pages 65804-65805]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 02-27404]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of a meeting of 
the National Cancer Institute Director's Consumer Liaison Group.
    The meeting will be open to the public, with attendance limited to 
space available. Individuals who plan to attend and need special 
assistance, such as sign language interpretation or other reasonable 
accommodations, should notify the Contact Person listed below in 
advance of the meeting.

    Name of Committee: National Cancer Institute Director's Consumer 
Liaison Group.
    Date: November 19, 2002.
    Time: 2 p.m. to 4 p.m.
    Agenda: To discuss the next steps for the DCLG with Dr. von 
Eschenbach and to get an update on the CARRA program.
    Place: 6166 Executive Blvd., Rockville, MD 20852, (Telephone 
Conference Call).
    Contact Person: Elaine Lee, Executive Secretary, Office of 
Liaison Activities, National Institutes of Health, National Cancer 
Institute, 6116 Executive Boulevard, Suite 300 C, Bethesda, MD 
20892, 301/594-3194.
    Any member of the public interested in presenting oral comments 
to the committee may notify the Contact Person listed on this notice 
at least 10 days in advance of the meeting. Interested individuals 
and representatives of organizations may submit a letter of intent, 
a brief description of the organization represented, and a short 
description of the oral presentation. Only one representative of an 
organization may be allowed to present oral comments and if accepted 
by the committee, presentations may be limited to five minutes. Both 
printed and electronic copies are requested for the

[[Page 65805]]

record. In addition, any interested person may file written comments 
with the committee by forwarding their statement to the Contact 
Person listed on this notice. The statement should include the name, 
address, telephone number and when applicable, the business or 
professional affiliation of the interested person.
    Information is also available on the Institute's/Center's home 
page: deainfo.nci.nih.gov/advisory/dclg/dclg.htm, where an agenda 
and any additional information for the meeting will be posted when 
available.

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer 
Control, National Institutes of Health, HHS)

    Dated: October 22, 2002.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 02-27404 Filed 10-25-02; 8:45 am]
BILLING CODE 4140-01-M